about
Methodological aspects of the molecular and histological study of prostate cancer: focus on PTENStratification and therapeutic potential of PML in metastatic breast cancerHepatic p63 regulates steatosis via IKKβ/ER stressThe metabolic co-regulator PGC1α suppresses prostate cancer metastasis.Transcriptomic profiling of urine extracellular vesicles reveals alterations of CDH3 in prostate cancer.mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer.Oil for the cancer engine: The cross-talk between oncogenic signaling and polyamine metabolism.PPARδ Elicits Ligand-Independent Repression of Trefoil Factor Family to Limit Prostate Cancer Growth.Low-dose statin treatment increases prostate cancer aggressiveness.Targeting PML in triple negative breast cancer elicits growth suppression and senescenceRe-evaluating statin activity in cancer
P50
Q27005677-C01F3714-4E5F-474C-9FED-FCB321D44813Q28387589-B02ACCE5-4F92-4C8C-B29F-77609EFE6996Q33654494-8EB743A3-C1A0-4538-A21A-51BC9FBA02C5Q36944849-45218401-F748-4DE8-83CD-832BF33EBEF2Q38803281-B1370EBB-9121-4798-9268-171F25F3B9E7Q47110074-68118774-3890-41E3-B34E-B9DDFC235BDEQ48154027-A21797C0-E13D-4304-AB7F-788C4205F0C9Q49541328-16690A45-02B0-41DD-AC14-DFBA01C9E3F0Q49823811-3C673FBB-5E17-435E-BD8F-F29D44E62ABEQ90391047-F5A97F87-78E4-4A14-898B-B53A04202C32Q90413321-0717D384-FD38-4531-A116-9BC3465F7D77
P50
description
investigador
@es
researcher
@en
name
Amaia Zabala-Letona
@en
type
label
Amaia Zabala-Letona
@en
prefLabel
Amaia Zabala-Letona
@en
P31
P496
0000-0003-2088-5195